Staphylococcus epidermidis endophthalmitis. Visual outcome following noninvasive therapy

Ophthalmology. 1982 Apr;89(4):354-60.

Abstract

Staphylococcus epidermidis has been reported with increasing frequency as a cause of bacterial endophthalmitis. Over the past eight years 18 consecutive postsurgical cases have been treated by combined antibiotic-corticosteroid therapy without intravitreal antibiotics or vitrectomy. Fourteen (78%) achieved a final visual acuity of 20/50 or better. When these cases were added to similarly reported cases in the literature, 72% achieved this level of vision. By contrast, 42% of adequately documented cases in the literature treated by intravitreal antibiotics, and 42% treated additionally by vitrectomy, achieved a vision of 20/50 or better. S. epidermidis is an organism with a low order of virulence. The use of intravitreal antibiotics and vitrectomy do not appear to be necessary for effective treatment.

MeSH terms

  • Administration, Topical
  • Adrenal Cortex Hormones / therapeutic use*
  • Adult
  • Aged
  • Anti-Bacterial Agents / therapeutic use*
  • Conjunctiva
  • Drug Therapy, Combination
  • Endophthalmitis / drug therapy*
  • Humans
  • Injections
  • Injections, Intravenous
  • Middle Aged
  • Staphylococcal Infections / drug therapy*
  • Surgical Wound Infection / drug therapy

Substances

  • Adrenal Cortex Hormones
  • Anti-Bacterial Agents